Quarter
Charts
πŸ‡ΊπŸ‡ΈUS Markets

Cullen/Frost Bankers, Inc.

CFR

CIK 0000039263 Β· Quarterly mode Β· latest period FY2025 (Q4) (ending 2025-12-31) Β· sourced from SEC EDGAR

At a glance Β· FY2025 (Q4)

Revenue
$581M
↑+8.3% +$45Mvs FY2024 (Q4)
Operating Income
$559M
↑+8.6% +$44Mvs FY2024 (Q4)
Net Income
$166M
↑+7.4% +$11Mvs FY2024 (Q4)
Gross Profit
$581M
↑+8.3% +$45Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot Β· latest annual filed values Β· S&P 500 calibration

Poor
7/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.04x (1.0+ = capital-efficient)
  • Growth
    44Revenue YoY +8.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CFR's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -41.0%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≀ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$27.73
Total enterprise IV
$1.78B
Diluted shares
0.06B
Terminal PV
$1.25B (70% of total)
Year-5 FCF
$148M
YearProjected FCFDiscounted PV
+1$131M$119M
+2$135M$112M
+3$139M$105M
+4$143M$98M
+5$148M$92M
Terminal$2.02B$1.25B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target β€” and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation Β· trailing 4 quarters

how the company spent its cash
Capex (TTM)
$147M
investment in PP&E
Dividends paid (TTM)
$255M
cash returned to holders
Stock buybacks (TTM)
$158M
share count reduction
Stock-based comp (TTM)
$25M
non-cash dilution

Balance sheet Β· 2025-12-31

latest filed snapshot
Total assets
$53.04B
everything owned
Total liabilities
$48.47B
everything owed
Stockholders' equity
$4.57B
shareholder claim

Recent performance Β· 67 quarters

Revenue↑+8.3% +$45M
$581M
Net Income↑+7.4% +$11M
$166M
Free Cash Flow↑+418.5% +$112M
$138M

Drill down